- Johnson & Johnson broke pivotal resistance level 194.00
- Likely to rise to resistance level 200.00
Johnson & Johnson recently broke above the pivotal resistance level 194.00, which stopped the previous impulse wave (3) in the middle of October.
The breakout of the resistance level 194.00 accelerated the active impulse wave 3 – which belongs to the intermediate impulse wave (5) from the end of October.
Given the strong daily uptrend, Johnson & Johnson can be expected to rise to the next round resistance level 200.00 (target for the completion of wave 3).
- Likely to rise to resistance level 200.00
Johnson & Johnson recently broke above the pivotal resistance level 194.00, which stopped the previous impulse wave (3) in the middle of October.
The breakout of the resistance level 194.00 accelerated the active impulse wave 3 – which belongs to the intermediate impulse wave (5) from the end of October.
Given the strong daily uptrend, Johnson & Johnson can be expected to rise to the next round resistance level 200.00 (target for the completion of wave 3).
By the FxPro Analyst Team
Follow our dedicated Telegram channel t.me/fxpro for insightful market analysis and expert commentary.
Reach out to media.comments@fxpro.com for PR and media inquiries
Follow our dedicated Telegram channel t.me/fxpro for insightful market analysis and expert commentary.
Reach out to media.comments@fxpro.com for PR and media inquiries
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
By the FxPro Analyst Team
Follow our dedicated Telegram channel t.me/fxpro for insightful market analysis and expert commentary.
Reach out to media.comments@fxpro.com for PR and media inquiries
Follow our dedicated Telegram channel t.me/fxpro for insightful market analysis and expert commentary.
Reach out to media.comments@fxpro.com for PR and media inquiries
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.